BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of “Buy” by Brokerages

Shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) have received an average rating of “Buy” from the five brokerages that are covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have updated their coverage on the stock […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set Dyne Therapeutics, Inc. (NYSE:DYN) Price Target at $27.20
Next post France September 2023: Peugeot 208 keeps Renault Clio at bay in market slowing down its growth